<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31959876</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-020-0755-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a severe disease causing motor neuron death, but a complete cure has not been developed and related genes have not been defined in more than 80% of cases. Here we compared whole genome sequencing results from a male ALS patient and his healthy parents to identify relevant variants, and chose one variant in the X-linked ATP7A gene, M1311V, as a strong disease-linked candidate after profound examination. Although this variant is not rare in the Ashkenazi Jewish population according to results in the genome aggregation database (gnomAD), CRISPR-mediated gene correction of this mutation in patient-derived and re-differentiated motor neurons drastically rescued neuronal activities and functions. These results suggest that the ATP7A M1311V mutation has a potential responsibility for ALS in this patient and might be a potential therapeutic target, revealed here by a personalized medicine strategy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yun</LastName><ForeName>Yeomin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Spine &amp; Spinal Cord Institute, College of Medicine, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hong</LastName><ForeName>Sung-Ah</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-3280-5677</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Hanyang University, Seoul, 04763, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ka-Kyung</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Daye</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Spine &amp; Spinal Cord Institute, College of Medicine, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dongsu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Londhe</LastName><ForeName>Ashwini M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul, 130-650, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Bio-Medical Science &amp; Technology, KIST School, Korea University of Science and Technology, Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Minhyung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology, Daejeon, 34113, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jihyeon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Hanyang University, Seoul, 04763, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEachin</LastName><ForeName>Zachary T</ForeName><Initials>ZT</Initials><Identifier Source="ORCID">0000-0002-2369-8726</Identifier><AffiliationInfo><Affiliation>Laboratory of Translational Cell Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassell</LastName><ForeName>Gary J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Cell Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowser</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, Phoenix, AZ, 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hales</LastName><ForeName>Chadwick M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Emory University, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Rae</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Janghwan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology, Daejeon, 34113, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pae</LastName><ForeName>Ae Nim</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul, 130-650, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Bio-Medical Science &amp; Technology, KIST School, Korea University of Science and Technology, Seoul, 02792, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Eunji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sangwoo</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5356-0827</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, 03722, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boulis</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sangsu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3615-8566</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Hanyang University, Seoul, 04763, South Korea. sangsubae@hanyang.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, South Korea. sangsubae@hanyang.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Yoon</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Spine &amp; Spinal Cord Institute, College of Medicine, Yonsei University, Seoul, 03722, South Korea. HAYOON@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, 03722, South Korea. HAYOON@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017394">RNA, Guide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 7.2.2.8</RegistryNumber><NameOfSubstance UI="C081184">ATP7A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 7.2.2.8</RegistryNumber><NameOfSubstance UI="D000073840">Copper-Transporting ATPases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="Y">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064112" MajorTopicYN="Y">Clustered Regularly Interspaced Short Palindromic Repeats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073840" MajorTopicYN="N">Copper-Transporting ATPases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="Y">Gene Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017394" MajorTopicYN="N">RNA, Guide, Kinetoplastida</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31959876</ArticleId><ArticleId IdType="pmc">PMC6970999</ArticleId><ArticleId IdType="doi">10.1038/s42003-020-0755-1</ArticleId><ArticleId IdType="pii">10.1038/s42003-020-0755-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA. 1977;74:5463&#x2013;5467. doi: 10.1073/pnas.74.12.5463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.74.12.5463</ArticleId><ArticleId IdType="pmc">PMC431765</ArticleId><ArticleId IdType="pubmed">271968</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol. Cell. 2015;58:586&#x2013;597. doi: 10.1016/j.molcel.2015.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.05.004</ArticleId><ArticleId IdType="pmc">PMC4494749</ArticleId><ArticleId IdType="pubmed">26000844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt B, Hildebrandt A. Next-generation sequencing: big data meets high performance computing. Drug Discov. today. 2017;22:712&#x2013;717. doi: 10.1016/j.drudis.2017.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2017.01.014</ArticleId><ArticleId IdType="pubmed">28163155</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Liu CY, Che CH, Huang HP. Toward precision medicine in amyotrophic lateral sclerosis. Ann. Transl. Med. 2016;4:27. doi: 10.21037/atm.2016.10.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2016.10.65</ArticleId><ArticleId IdType="pmc">PMC4731596</ArticleId><ArticleId IdType="pubmed">26889480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bis, J. C., et al. Whole exome sequencing study identifies novel rare and common Alzheimer&#x2019;s-Associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry, 10.1038/s41380-018-0112 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375806</ArticleId><ArticleId IdType="pubmed">30108311</ArticleId></ArticleIdList></Reference><Reference><Citation>Cukier HN, et al. Exome sequencing of extended families with Alzheimer&#x2019;s disease identifies novel genes implicated in cell immunity and neuronal function. J. Alzheimer&#x2019;s Dis. Parkinsonism. 2017;7:pii: 355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698805</ArticleId><ArticleId IdType="pubmed">29177109</ArticleId></ArticleIdList></Reference><Reference><Citation>Farlow JL, et al. Whole-exome sequencing in familial Parkinson disease. JAMA Neurol. 2016;73:68&#x2013;75. doi: 10.1001/jamaneurol.2015.3266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.3266</ArticleId><ArticleId IdType="pmc">PMC4946647</ArticleId><ArticleId IdType="pubmed">26595808</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen RK, et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat. Med. 2015;21:185&#x2013;191. doi: 10.1038/nm.3792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3792</ArticleId><ArticleId IdType="pubmed">25621899</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng G, et al. Rare variant detection using family-based sequencing analysis. Proc. Natl Acad. Sci. USA. 2013;110:3985&#x2013;3990. doi: 10.1073/pnas.1222158110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222158110</ArticleId><ArticleId IdType="pmc">PMC3593912</ArticleId><ArticleId IdType="pubmed">23426633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A, et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat. Neurosci. 2013;16:851&#x2013;855. doi: 10.1038/nn.3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front. Cell. Neurosci. 2015;9:289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4523944</ArticleId><ArticleId IdType="pubmed">26300727</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526:336&#x2013;342. doi: 10.1038/nature15816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15816</ArticleId><ArticleId IdType="pmc">PMC5669797</ArticleId><ArticleId IdType="pubmed">26469044</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldner F, Jaenisch R. Medicine. iPSC disease modeling. Science (New York, NY) 2012;338:1155&#x2013;1156. doi: 10.1126/science.1227682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1227682</ArticleId><ArticleId IdType="pubmed">23197518</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrangou R, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science (New York, NY) 2007;315:1709&#x2013;1712. doi: 10.1126/science.1138140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1138140</ArticleId><ArticleId IdType="pubmed">17379808</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P, et al. RNA-guided human genome engineering via Cas9. Science (New York, NY) 2013;339:823&#x2013;826. doi: 10.1126/science.1232033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232033</ArticleId><ArticleId IdType="pmc">PMC3712628</ArticleId><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013;8:2281&#x2013;2308. doi: 10.1038/nprot.2013.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.143</ArticleId><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014;32:347&#x2013;355. doi: 10.1038/nbt.2842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2842</ArticleId><ArticleId IdType="pmc">PMC4022601</ArticleId><ArticleId IdType="pubmed">24584096</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaj T, et al. In vivo genome editing improves motor function and extends survival in a mouse model of ALS. Sci. Adv. 2017;3:eaar3952. doi: 10.1126/sciadv.aar3952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aar3952</ArticleId><ArticleId IdType="pmc">PMC5738228</ArticleId><ArticleId IdType="pubmed">29279867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N, et al. Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR/Cas9 and human-induced pluripotent stem cells. Circulation. 2018;138:2666&#x2013;2681. doi: 10.1161/CIRCULATIONAHA.117.032273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.032273</ArticleId><ArticleId IdType="pmc">PMC6298866</ArticleId><ArticleId IdType="pubmed">29914921</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, et al. Reversal of phenotypic abnormalities by CRISPR/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep. 2017;8:619&#x2013;633. doi: 10.1016/j.stemcr.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC5355646</ArticleId><ArticleId IdType="pubmed">28238795</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Prognostic factors in ALS: a critical review. Amyotroph. Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. II. Neurology. 1955;5:249&#x2013;268. doi: 10.1212/WNL.5.4.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.5.4.249</ArticleId><ArticleId IdType="pubmed">14370376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A, Namboori SC, Zhang X, VanDongen AMJ, Stanton LW. Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis. Stem Cell Rep. 2017;8:856&#x2013;869. doi: 10.1016/j.stemcr.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795. doi: 10.1016/j.stem.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, et al. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Protein Cell. 2017;8:365&#x2013;378. doi: 10.1007/s13238-017-0397-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0397-3</ArticleId><ArticleId IdType="pmc">PMC5413600</ArticleId><ArticleId IdType="pubmed">28401346</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351. doi: 10.1002/humu.22157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22157</ArticleId><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok K, et al. Homozygosity analysis in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 2013;21:1429&#x2013;1435. doi: 10.1038/ejhg.2013.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2013.59</ArticleId><ArticleId IdType="pmc">PMC3829775</ArticleId><ArticleId IdType="pubmed">23612577</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton JB, White AR, Crouch PJ. Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS. Metallomics: Integr. Biometal Sci. 2016;8:1002&#x2013;1011. doi: 10.1039/C6MT00099A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MT00099A</ArticleId><ArticleId IdType="pubmed">27357743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheykhansari S, et al. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death Dis. 2018;9:348. doi: 10.1038/s41419-018-0379-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0379-2</ArticleId><ArticleId IdType="pmc">PMC5832817</ArticleId><ArticleId IdType="pubmed">29497049</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Kaler S. ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A. Ann. N. Y. Acad. Sci. 2014;1314:49&#x2013;54. doi: 10.1111/nyas.12427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12427</ArticleId><ArticleId IdType="pmc">PMC4041065</ArticleId><ArticleId IdType="pubmed">24754450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaler SG. ATP7A-related copper transport diseases-emerging concepts and future trends. Nat. Rev. Neurol. 2011;7:15&#x2013;29. doi: 10.1038/nrneurol.2010.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.180</ArticleId><ArticleId IdType="pmc">PMC4214867</ArticleId><ArticleId IdType="pubmed">21221114</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lim K, Kim JS, Bae S. Cas-analyzer: an online tool for assessing genome editing results using NGS data. Bioinformatics (Oxford, England) 2017;33:286&#x2013;288. doi: 10.1093/bioinformatics/btw561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw561</ArticleId><ArticleId IdType="pmc">PMC5254075</ArticleId><ArticleId IdType="pubmed">27559154</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Park J, Kim JS. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics (Oxford, England) 2014;30:1473&#x2013;1475. doi: 10.1093/bioinformatics/btu048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu048</ArticleId><ArticleId IdType="pmc">PMC4016707</ArticleId><ArticleId IdType="pubmed">24463181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr. Drug Metab. 2012;13:237&#x2013;250. doi: 10.2174/138920012799320455.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920012799320455</ArticleId><ArticleId IdType="pmc">PMC3290776</ArticleId><ArticleId IdType="pubmed">21838703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PloS ONE. 2012;7:e39715. doi: 10.1371/journal.pone.0039715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039715</ArticleId><ArticleId IdType="pmc">PMC3401209</ArticleId><ArticleId IdType="pubmed">22911689</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehmelt L, Halpain S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 2005;6:204. doi: 10.1186/gb-2004-6-1-204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2004-6-1-204</ArticleId><ArticleId IdType="pmc">PMC549057</ArticleId><ArticleId IdType="pubmed">15642108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton MA, et al. Loss of microtubule-associated protein 2 immunoreactivity linked to dendritic spine loss in schizophrenia. Biol. Psychiatry. 2015;78:374&#x2013;385. doi: 10.1016/j.biopsych.2014.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.12.029</ArticleId><ArticleId IdType="pmc">PMC4520801</ArticleId><ArticleId IdType="pubmed">25818630</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng J, et al. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J. Cell Biol. 2001;155:65&#x2013;76. doi: 10.1083/jcb.200106025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200106025</ArticleId><ArticleId IdType="pmc">PMC2150794</ArticleId><ArticleId IdType="pubmed">11581286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, et al. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res. 2014;24:126&#x2013;129. doi: 10.1038/cr.2013.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.156</ArticleId><ArticleId IdType="pmc">PMC3879704</ArticleId><ArticleId IdType="pubmed">24296783</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M, et al. Copper-transporting P-type ATPases use a unique ion-release pathway. Nat. Struct. Mol. Biol. 2014;21:43&#x2013;48. doi: 10.1038/nsmb.2721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2721</ArticleId><ArticleId IdType="pmc">PMC3904665</ArticleId><ArticleId IdType="pubmed">24317491</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, et al. Solution structures of the actuator domain of ATP7A and ATP7B, the Menkes and Wilson disease proteins. Biochemistry. 2009;48:7849&#x2013;7855. doi: 10.1021/bi901003k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi901003k</ArticleId><ArticleId IdType="pubmed">19645496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bublitz M, Morth JP, Nissen P. P-type ATPases at a glance. J. Cell Sci. 2011;124:2515&#x2013;2519. doi: 10.1242/jcs.088716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.088716</ArticleId><ArticleId IdType="pubmed">21768325</ArticleId></ArticleIdList></Reference><Reference><Citation>Gourdon P, Sitsel O, Lykkegaard Karlsen J, Birk Moller L, Nissen P. Structural models of the human copper P-type ATPases ATP7A and ATP7B. Biol. Chem. 2012;393:205&#x2013;216. doi: 10.1515/hsz-2011-0249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2011-0249</ArticleId><ArticleId IdType="pubmed">23029640</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian M, et al. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with de novo, heterozygous, loss-of-function mutations in ASXL3 and review of published literature. J. Med. Genet. 2017;54:537&#x2013;543. doi: 10.1136/jmedgenet-2016-104360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-104360</ArticleId><ArticleId IdType="pubmed">28100473</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang ML, et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing. Proc. Natl Acad. Sci. USA. 2016;113:9846&#x2013;9851. doi: 10.1073/pnas.1607794113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607794113</ArticleId><ArticleId IdType="pmc">PMC5024639</ArticleId><ArticleId IdType="pubmed">27528664</ArticleId></ArticleIdList></Reference><Reference><Citation>Minikel EV, et al. Quantifying prion disease penetrance using large population control cohorts. Sci. Transl. Med. 2016;8:322ra329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4774245</ArticleId><ArticleId IdType="pubmed">26791950</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemi MEK, et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature. 2018;562:268&#x2013;271. doi: 10.1038/s41586-018-0566-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0566-4</ArticleId><ArticleId IdType="pmc">PMC6726472</ArticleId><ArticleId IdType="pubmed">30258228</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen CI, et al. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome&#x2014;a clinical study of 11 individuals. Am. J. Med. Genet. Part A. 2018;176:1108&#x2013;1114. doi: 10.1002/ajmg.a.38610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.38610</ArticleId><ArticleId IdType="pubmed">29383814</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T, et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat. Neurosci. 2016;19:571&#x2013;577. doi: 10.1038/nn.4267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4267</ArticleId><ArticleId IdType="pmc">PMC6689268</ArticleId><ArticleId IdType="pubmed">26974950</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen, W. et al. (Collaborators). Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Human Genetics26, 1537&#x2013;1546 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle nerve. 1995;18:741&#x2013;752. doi: 10.1002/mus.880180711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180711</ArticleId><ArticleId IdType="pubmed">7783764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph. lateral Scler. frontotemporal degeneration. 2013;14(Suppl 1):5&#x2013;18. doi: 10.3109/21678421.2013.778548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778548</ArticleId><ArticleId IdType="pmc">PMC3779649</ArticleId><ArticleId IdType="pubmed">23678876</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle EA, Li YI, Pritchard JK. An Expanded View of Complex Traits: From Polygenic to Omnigenic. Cell. 2017;169:1177&#x2013;1186. doi: 10.1016/j.cell.2017.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.038</ArticleId><ArticleId IdType="pmc">PMC5536862</ArticleId><ArticleId IdType="pubmed">28622505</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia AM, et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 2017;7:10046. doi: 10.1038/s41598-017-10488-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam L, et al. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients. FASEB J. 2016;30:3461&#x2013;3473. doi: 10.1096/fj.201600259RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600259RR</ArticleId><ArticleId IdType="pmc">PMC5024692</ArticleId><ArticleId IdType="pubmed">27368295</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75&#x2013;93. doi: 10.1016/j.brainres.2014.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.10.009</ArticleId><ArticleId IdType="pmc">PMC5916786</ArticleId><ArticleId IdType="pubmed">25316630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JE, Hwang S, Lee I. Pathway-dependent effectiveness of network algorithms for gene prioritization. PloS ONE. 2015;10:e0130589. doi: 10.1371/journal.pone.0130589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0130589</ArticleId><ArticleId IdType="pmc">PMC4474432</ArticleId><ArticleId IdType="pubmed">26091506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 2008;9(Suppl 1):S4. doi: 10.1186/gb-2008-9-s1-s4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2008-9-s1-s4</ArticleId><ArticleId IdType="pmc">PMC2447538</ArticleId><ArticleId IdType="pubmed">18613948</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362&#x2013;d368. doi: 10.1093/nar/gkw937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw937</ArticleId><ArticleId IdType="pmc">PMC5210637</ArticleId><ArticleId IdType="pubmed">27924014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell. 2010;7:90&#x2013;100. doi: 10.1016/j.stem.2010.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.04.017</ArticleId><ArticleId IdType="pmc">PMC2904346</ArticleId><ArticleId IdType="pubmed">20621053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>